Lonza | LONN - Ativo Circulante





Ativo Circulante Alterar Data
Akzo Nobel EUR 7.53B 1.47B 2026-03
Alcon AG USD 6.62B 171M 2026-03
Almirall EUR 713.98M 69K 2025-12
AstraZeneca USD 29.61B 890M 2026-03
BASF EUR 31.68B 1.4B 2025-12
Bayer EUR 35.3B 2.39B 2026-03
Beiersdorf EUR 6.66B 8M 2025-12
Covestro EUR 5.91B 259M 2025-12
Demant DKK 10.08B 128M 2025-12
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Geberit CHF 1.13B 151.3M 2024-12
Genmab DKK 2.88B 1.59B 2025-12
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GN Store Nord DKK 4.85B 3.79B 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Johnson Matthey GBP 3.83B 320M 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Philips EUR 9.78B 148M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sika AG CHF 4.41B 242.1M 2025-12
Smith & Nephew USD 4.63B 169M 2025-12
Solvay EUR 2.19B 34M 2026-03
UCB EUR 6.05B 733M 2025-12